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Abstract
Purpose Lymphoma survivors experience persisting needs as a consequence of disease and treatment, which have an impact on
quality of life (QoL). There is evidence supporting the use of relaxation and exercise to improve QoL, but there is no agreement
on which is more beneficial. This study aims to compare a relaxation intervention versus an exercise intervention to determine
which has a greater impact on QoL post-chemotherapy.
Methods Eligible participants (n = 46) were randomised to a relaxation or exercise intervention for 12 weeks. QoL was assessed
at baseline, 6 weeks and post-intervention using the European Organisation for Research and Treatment of Cancer QoL
Questionnaire Core 30 (EORTC QLQ-C30) questionnaire, which is a valid and reliable tool. The summary score and all
EORTC domains were assessed.
Results There was a significant difference in QoL post-intervention between groups (p = 0.029) while adjusting for baseline
QoL, with the exercise group demonstrating a larger improvement. Within-group QoL significantly improved pre- to post-
intervention in both the relaxation (p = 0.036) and exercise (p = 0.004) groups.
Conclusions A self-management intervention of either exercise or relaxation can help significantly improve QoL in lymphoma
survivors following chemotherapy. While exercise is preferred, a relaxation intervention would also have a beneficial impact on
QoL.
Implications for Cancer Survivors Lymphoma survivors should be routinely screened and those with decreased QoL referred for
an exercise programme, or relaxation for survivors who are unable to exercise or choose not to. A home-based programme can
have a significant positive impact on QoL and is a feasible and effective method in the current climate.
Trial registration number Clinical Trials ID NCT02272751
Keywords Lymphoma survivors . Exercise . Relaxation . Self-management . Quality of life
Introduction
It is well recognised that a large number of haematological
cancer survivors continue to experience physical and psycho-
logical unmet needs following treatment, resulting in a de-
creased quality of life (QoL) [1–3]. It is also recognised that
the immediate period following treatment is a particularly dif-
ficult time, when survivors may feel isolated and abandoned
[4–6]. Several studies [7–10] have been carried out to assess
the effectiveness of various rehabilitation interventions on
QoL in cancer survivors. Some studies support the use of
exercise such as aerobic and/or resistance training [7, 8], while
others recommend the use of relaxation techniques including
mindfulness-based stress reduction, progressive muscle relax-
ation and guided imagery [9, 10]. Both interventions appear to
have a positive effect on QoL, but there is no consensus on
which is more effective, and no standardised pathways follow-
ing chemotherapy, despite the fact that cancer survivors report
a need for further support during this transition phase [11]. In
the majority of these studies, the relaxation or exercise inter-
ventions have been compared with a control group, and there
has been a call for future studies to rule out potential placebo
effects and compare with active control or other empirically
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Studies on cancer survivors have been carried out in vari-
ous settings, including both group-based supervised
programmes and self-management. Recent systematic re-
views and meta-analyses of RCTs of exercise for cancer pa-
tients and survivors have reported significant beneficial effects
for supervised exercise interventions on QoL and a lesser ef-
fect for unsupervised [14, 15]. This could be due to greater
direction and motivation from a trainer and access to equip-
ment. However, Swartz et al. [16] highlight that while there is
evidence that exercise can improve the QoL of cancer survi-
vors, few interventions have been translated into practice. This
could be due to trial designs with high resources and clinical
settings, and these authors suggest that home-based interven-
tions may be a way of enabling the translation from research to
practice [16]. Similarly, despite evidence of the efficacy of
relaxation programmes for cancer survivors, the training and
resources required to provide professionally administered psy-
chosocial interventions can be a major barrier to their routine
use [17]. Hence, although home-based programmes appear to
have lower efficacy than supervised programmes, their greater
accessibility, wider reach and potential long-term sustainabil-
ity may make a self-managed approach also beneficial to
survivors.
Furthermore, there is a drive towards self-management for
cancer survivors, with the National Cancer Survivorship
Initiative (NCSI) in the United Kingdom (UK) calling for a
need to increase service user involvement and self-
management [4]. Self-management can empower cancer pa-
tients and survivors, increase their confidence to manage
problems associated with the disease and its treatment and
enhance the quality of life [4, 18]. Survivors themselves have
reported a preference for home-based self-management over
group classes in a clinical setting [19–21]. In addition, due to
the present COVID-19 pandemic, efforts are being made to
reduce the exposure of cancer survivors to the virus [22].
Hence, effective, evidence-based self-management interven-
tions are more pertinent now. The majority of survivorship
studies have been carried out on the most prevalent cancers
such as breast and prostate cancer [9, 10, 23], and there is a
lack of studies on other cancer groups [1, 23] including hae-
matological cancers such as lymphoma.
The Relaxation and Exercise In Lymphoma survivors
(REIL) study was carried out to address some of these issues
[24]. The REIL study aims to compare the effect of two home-
based interventions onQoL in a group of lymphoma survivors
within 6 weeks post-chemotherapy to determine which
intervention—relaxation or exercise—results in a larger im-
pact on QoL. The REIL study is the first randomised con-
trolled trial (RCT) comparing home-based relaxation with a
home-based exercise programme in lymphoma survivors fol-
lowing chemotherapy. Results will contribute to a better un-
derstanding of the efficacy of these interventions and build
towards the implementation of evidence-based programmes
to improve QoL in lymphoma survivors. This paper presents
findings from the primary outcome measure, the European
Organisation for Research and Treatment of Cancer Quality
of Life Questionnaire Core 30 (EORTC QLQ-C30, version
3.0) [25, 26]. Secondary results will be reported elsewhere.
Aim
To compare the effect of two home-based interventions (re-




The REIL study is a randomised clinical intervention trial.
Participants who consented were randomised to a relaxation
or an exercise intervention. Outcome measures were assessed
at baseline prior to intervention, at 6 weeks, and on comple-
tion of the 12-week intervention.
Ethical approval
The study received ethical approval from Camden and
Islington National Research Ethics Service (13/LO/1327),
and from St. George’s Hospital Joint Research and
Enterprise Office (JREO) (13.0108) where the research was
carried out. The study is registered on a publicly accessible
database, ClinicalTrials.gov, NCT02272751.
Participants
Eligible participants included patients with histologically con-
firmed lymphoma in remission post-chemotherapy, chemo-
therapy treatment completed within the last 6 weeks, age
18 years or older, able to give informed consent, good perfor-
mance status (assessed by the Eastern Cooperative Oncology
Group [ECOG] status 0–2) [27] and medically able to under-
take exercise. The following were exclusion criteria—patients
with active disease, unstable angina or unexplained electro-
cardiogram, poor performance status (ECOG status 3 or
more), pregnancy, difficulty breathing at rest, persistent
cough, fever or illness, or any cognitive impairment limiting
the ability to give informed consent or complete QoL ques-
tionnaires. Informed consent was obtained from all partici-
pants, and participants were informed that they could with-
draw at any time. At baseline, patient demographics including
gender, age, social history and medical history were recorded.
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Study settings
Participants were recruited from a single National Health
Service (NHS) setting—the Haematology-Oncology Out-
Patient (HOOP) Clinic at St George’s Hospital, London.
Assessment for eligibility, recruitment, medical screening
and obtaining informed consent was carried out by the pa-
tients’ medical consultant (RP). Assessment of outcome mea-
sures and delivery of interventions were carried out by the
principal investigator (SH) following participants’ scheduled
follow-up appointments.
Interventions—relaxation and exercise
The relaxation intervention comprised an audio CD incorpo-
rating relaxation techniques including mindfulness medita-
tion, deep breathing exercises, guided visualisation and pro-
gressive muscular relaxation. The exercise intervention com-
prised a programme of aerobic, upper and lower limb resis-
tance exercise, core stability and stretches to be performed
independently at home. Both interventions are described in
detail in the REIL study protocol [24]. This protocol was
adhered to throughout the study. Both interventions were sim-
ilar in aspects including location (home), frequency and dura-
tion (50 min three times a week for 12 weeks). Participants in
both groups also had equal contact with the researcher, ap-
proximately 3 h (1 h for each assessment and education ses-
sion), and were able to call researcher for advice whenever
needed. Both groups were provided with written information
and resources including audio and visual aids to enable self-
management. Participants in both groups were advised to con-
tinue to resume their normal activity as able, with their inter-
vention as a supplement to normal habit [24].
Outcome measures
The primary outcome measure is QoL, assessed by the
EORTC QLQ-C30 summary score. The QLQ-C30 is a mul-
tidimensional health-related QoL questionnaire. This self-
reported questionnaire is recognised as a valid and reliable
tool and is the most widely used outcome measure used to
assess QoL in cancer survivorship research [28]. Although
the QLQ-C30 provides a wealth of information about QoL,
a challenge is the multiple outcomes it generates. As a result,
the EORTC group introduced and tested a single summary
score of the QLQ-C30 questionnaire [29]. In addition to re-
ducing the risk to type I errors, the use of the summary score
can also ensure direct comparability between studies [29]. The
EORTC group now recommends the use of the summary
score and this was the primary outcome measure for the
REIL study. The summary score and other EORTC domains
were assessed at all three time points.
Sample size
Sample size was calculated to determine clinically relevant
effects on the primary outcome measure. A minimally impor-
tant difference of 10 points in the EORTC QLQ-C30 score is
generally accepted as clinically meaningful [30], and calcula-
tions were based on comparison of means between two
groups. It was determined that a minimum 46 participants
was required to detect a significant change in the EORTC
summary score. This calculation assumed a two-sided signif-
icance level (α) of 0.05, power of 80% (ß = 0.20), a standard
deviation from EORTC website reference values and a drop-
out rate of 34% as reported in similar studies [31]. Based on
this, a minimum of 23 participants was required in each group.
Randomisation
Participants were assigned to either the relaxation or exercise
group using a computer-generated random allocation list. This
was prepared independently by a biostatistician otherwise un-
involved in the study using randomisation software and saved
on a secure database that could not be modified by the re-
searchers. Each participant was assigned an anonymous ID
number on enrolment, and each number allocated the inter-
vention on the list.
All assessments were carried out by the principal investi-
gator (SH); hence, it was not possible to blind the investigator
to intervention. Participants also could not be blinded due to
the nature of the intervention.
Data analysis
Data was entered into the Microsoft Excel (2013) database by
SH and analysed with support from the other researchers and a
statistician independent of the study using IBM SPSS version
22 (SPSS, Inc., Chicago, IL) statistical software package.
Summary scores plus scores from all other questionnaire do-
mains were calculated as recommended by the EORTC scor-
ing manual, missing data handled as recommended by scoring
guidelines. Data was first assessed to check distribution using
a combination of visual inspection, assessment of skewness
and kurtosis and formal normality tests (Shapiro–Wilk). All
data followed a normal distribution. Significance testing of
baseline differences in a randomised sample is discouraged
by CONSORT guidelines [32] and this was not performed;
descriptive statistics are used to describe baseline characteris-
tics of both groups. Analysis of covariance (ANCOVA) was
used to compare differences in the QoL at 12 weeks using
baseline QoL as a covariate. Post hoc paired-sample t tests
for comparison pre-post intervention was tested within groups
with the Bonferroni corrections.
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Results
Participants
Participants were recruited from September 2014 to
December 2016. Sixty-two potential participants were
approached. Of these, 46 (29 female and 17 male) consented
and were enrolled in the study, 23 randomised to each inter-
vention. Participant demographics are summarised in Table 1.
Five participants failed to complete the study (n = 3 relaxation,
n = 2 exercise), reasons included no time (n= 3), not interested
(n = 1) and disease progression (n = 1). This demonstrated a
dropout rate of 13% for the relaxation group and 9% for the
exercise group. Little’sMCAR test indicated that dataweremiss-
ing completely at random, and pairwise deletion for complete
case analysis was applicable for this dataset. The CONSORT
flow diagram of the study is presented in Fig. 1. No adverse
events or injuries were reported in either group.
Between-group effect—QLQ-C30 summary score
There was a significant difference in QoL between the two
groups at 12 weeks (F(1, 35) = 5.208, p = 0.029; 95% CI
0.608–10.413) while adjusting for baseline. The effect size
observed was large (partial eta squared = 0.130). The mean
adjusted QoL summary score at 12 weeks was 91.07 (95%
CI 86.69–93.58) for the exercise group and 83.68 (95% CI
81.18–88.07) for the relaxation group, indicating a beneficial
effect of exercise vs. relaxation. Mean values of the summary
score at 12 weeks and all EORTC domains are summarised in
Table 2.
Table 1 Baseline demographics
Total sample, n = 46 Relaxation, n = 23 Exercise, n = 23
Age, years (mean + SD) 61 (+ 16.7) 60.4 (+ 19.4) 61.5 (+ 13.9)
Gender (n, %)
Male 17 (37) 7 (30.4) 10 (43.5)
Female 29 (63) 16 (69.6) 13 (56.5)
Marital status (n, %)
Married/partner 31 (67) 14 (61) 17 (74)
Single 10 (22) 4 (17) 6 (26)
Widowed 5(11) 5 (22) 0 (0)
Ethnicity (n, %)
Caucasian 38 (83) 18 (78.3) 20 (87.1)
Asian 4 (9) 3 (13) 1 (4.3)
Afro-Caribbean 3 (6) 2 (8.7) 1 (4.3)
Other 1 (2) 0 (0) 1 (4.3)
Comorbidities (n, %)
None 14 (30.4) 6 (26.1) 8 (34.8)
1 16 (34.8) 5 (21.7) 11 (47.8)
2 10 (21.7) 6 (26.1) 4 (17.4)
3 or more 6 (13.1) 6 (26.1) 0 (0)
ECOG status (n, %)
0 7 (15) 4 (17.4) 3 (13)
1 18 (39) 7 (30.4) 11 (48)
2 21 (46) 12 (52.2) 9 (39)
Employment (n, %)
Retired 21 (45.7) 11 (47.8) 10 (43.6)
Sick leave 9 (19.6) 4 (17.5) 5 (21.6)
Fulltime work 7 (15.3) 3 (13) 4 (17.5)
Homemaker 4 (8.6) 3 (13) 1 (4.3)
Part-time work 2 (4.3) 0 (0) 2 (8.7)
Unemployed 1 (2.2) 0 (0) 1 (4.3)
Other 2 (4.3) 2 (8.7) 0 (0)
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Fig. 1 Participant flow
Table 2 EORTC QLQ-C30
domains—means (+ SD) of both
groups and between-group com-
parison, adjusted for baseline.
*Indicates significant difference
between groups
Mean 12-week relaxation Mean 12-week exercise p=
Summary score 83.69 + 11.34 91.07 + 7.03 0.029*
Physical function 77.54 + 18.02 89.21 + 11.03 0.038*
Role function 81.58 + 24.15 87.72 + 14.53 0.441
Emotional function 82.02 + 20.65 88.60 + 15.01 0.267
Cognitive function 78.07 + 16.71 86.84 + 17.19 0.367
Social function 87.72 + 17.43 92.10 + 17.01 0.444
Fatigue 35.67 + 22.40 17.54 + 18.63 0.009*
Nausea/vomiting 4.39 + 7.54 0.88 + 3.82 0.080
Pain 14.04 + 14.97 5.26 + 9.71 0.017*
Dyspnoea 19.30 + 23.08 10.56 + 15.92 0.093
Insomnia 17.54 + 23.22 5.26 + 12.49 0.155
Appetite loss 10.53 + 19.41 8.77 + 15.08 0.588
Constipation 10.53 + 19.41 8.77 + 15.08 0.588
Diarrhoea 7.02 + 17.84 3.51 + 10.51 0.342
Financial problems 8.77 + 24.45 7.41 + 18.28 0.911
Global QoL 74.12 + 15.93 80.70 + 15.48 0.374
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Other QLQ-C30 domains
There was a significant difference between the two groups for
physical function (PF) (F(1, 35) = 4.642, p = 0.038; 95% CI
0.465–15.662), fatigue (F(1, 35) = 7.763, p = 0.009, 95% CI
4.339–27.640) and pain (F(1, 35) = 6.268, p = 0.017, 95% CI
1.610–15.418) subscales, adjusting for baseline values.
There were no significant differences between groups for
other subscales.
Improvement over time
Within-group analyses demonstrated a significant difference
in pre-post QoL summary score in both groups—mean differ-
ence pre-post in the relaxation group was 6.198 (± 11.92), p =
0.036, 95% CI 0.453–11.943; and in the exercise group, the
mean difference was 8.839 (±11.563), p = 0.004, 95% CI
3.266–14.413. Within-group improvement in QoL from base-
line to 12 weeks is demonstrated in Fig. 2.
Discussion
The aim of this study was to compare the effect of two home-
based interventions on QoL in a sample of lymphoma survi-
vors within 6 weeks post-chemotherapy. Results indicate a
significant difference between the groups following interven-
tion, with the exercise group demonstrating a larger improve-
ment in overall QoL than the relaxation group. A significant
difference between groups in PF, fatigue and pain symptom
scales was also observed, once again with the exercise group
demonstrating a larger improvement in these domains.
Similar to this study, other studies on exercise in cancer
survivors have similarly demonstrated a positive effect on
QoL and other outcomes closely related to QoL such as PF,
fatigue and pain [7, 14, 15, 33, 34]. Exercise has been shown
to have a significant positive effect on physical factors includ-
ing body weight, body mass index, muscle strength, aerobic
fitness, fatigue and functional ability in cancer survivors, as
well as psychological factors including distress, anxiety and
depression [13, 32, 35, 36]. Hence, several national and inter-
national cancer organisations recommend exercise for cancer
survivors [37–40].
Following these findings, it can be argued that a home-
based exercise programme post-chemotherapy is more effec-
tive at improving QoL than a relaxation programme. It must
be highlighted however that while the exercise group demon-
strated a larger improvement, the relaxation group also dem-
onstrated a significant difference in QoL following interven-
tion. Other studies have also reported improvements in QoL
following a relaxation programme [9, 41]. While the mecha-
nism and physiology of relaxation are different from under-
taking exercise, relaxation techniques have also shown to have
a positive effect on physical and psychological symptoms in
cancer survivors including pain, fatigue, quality of life, anxi-
ety and depression [9, 41–43]. The use of complementary and
alternative medicine (CAM) including relaxation techniques
is growing in popularity, and it is reported that cancer survi-
vors are more likely to use CAM than the general population
[44]. Up to 89% of survivors report the use of CAM including
mind-body approaches such as relaxation [45, 46], choosing
to do so without being advised by a healthcare professional.
Hence, a proportion of cancer and lymphoma survivors may
have a preference for relaxation programmes. Hence, as the
results of this study also indicate, the benefits of relaxation
should not be overlooked, and both these interventions are
beneficial to cancer survivors—relaxation could be consid-
ered an effective alternative intervention to offer to survivors
who chose to or who are unable to exercise.
While studies have shown the effectiveness of
mindfulness-based stress reduction (MBSR) on QoL, the tra-





















Fig. 2 Mean QOL over time at
baseline, 6 weeks and 12 weeks
(dark grey line represents exercise
intervention; light grey line
represents relaxation
intervention)
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commitment and this could be a reason for non-adherence or
even non-participation [47]. The authors have acknowledged
there is scope to tailor the intervention so that it is less inten-
sive, for instance, less time-consuming for the participant [47].
The relaxation intervention used in the REIL study meets
criteria described for low-intensity interventions—
administered in non-face-to-face setting, delivered by a non-
mental health practitioner (delivered by a physiotherapist
specialising in oncology), be more accessible (programme
available in their NHS follow-up clinic) and be briefer for
the practitioner compared to therapist delivered treatments
[48]. Hence, this home-based relaxation programme is a fea-
sible and realistic intervention for improving the QoL of lym-
phoma survivors unable to exercise.
It is recognised that cancer survivors suffering from comor-
bid conditions such as heart disease, hypertension, asthma/
COPD, diabetes and osteoarthritis experience lower levels of
QoL [49]. While exercise has a beneficial impact on a variety
of these comorbid conditions, these survivors may require
close monitoring and exercise under supervision. For this
group, a self-managed home relaxation programme may help
to improve their QoL, if they are unable to perform unsuper-
vised exercise to do so, or experience any contraindications.
Other groups of survivors may have a preference towards
relaxation for a variety of other reasons including previous
history of complementary and alternative medicine (CAM)
use, or dislike of exercise. This group may also benefit from
a self-managed relaxation programme if experiencing ongo-
ing symptoms leading to decreased QoL.
Lymphoma survivors experience a heterogeneity of unmet
needs [50]—while some complain of no needs following che-
motherapy, others experience symptoms ranging from physi-
cal (e.g. fatigue, pain, nausea) and/or psychological (e.g. anx-
iety, depression, insomnia). This wide range of baseline needs
complicate the provision of adequate support, and a flexible
approach is required with opportunity to access different types
of support at different times post-treatment [6], based on indi-
vidual need and preference. It is widely recommended that
interventions are tailored for individual patients and that pa-
tient choice should be a key feature in survivorship care [4].
As both the relaxation and exercise interventions improved
QoL, offering a choice to patients who experience decreased
QoL could be a way towards the flexible, tailored approach
recommended for survivorship care. The main focus should
be the assessment of survivors and identifying those in need of
support to improve QoL.
As not all cancer survivors experience unmet needs and
decreased QoL, some cancer survivors may not feel the need
to undertake self-management practices as they feel they al-
ready have a good QoL [51]. This was seen in the REIL study,
where some participants reported no unmet needs following
chemotherapy and found no benefit from a home-based inter-
vention [11]. The sample of lymphoma survivors in this study
was already fairly active, as participants had to have an ECOG
performance status of 0–2 [27] which ranged from fully active
without restriction to mobile and capable of all self-care but
unable to carry out work activities in order to be included in
the study. Patients who were capable of limited self-care or
confined to a bed or chair more than 50% of waking hours
were excluded from the study; hence, the results could be
affected by potential ceiling effects in the patient-reported
outcome measure, where baseline QoL was a good score
(higher score for summary score and function scales, and low-
er score for symptom scales) and thus less sensitive to change.
More importantly, those with severe comorbidities resulting in
a greater decrease in QoL and possibly in greater need of
intervention (either relaxation or exercise) and support may
have been excluded from this study if they did not meet per-
formance status criteria or were unable to exercise indepen-
dently. Hence, it is important to assess which survivors are
most likely to benefit from an intervention programme,
whether relaxation or exercise, and target those with the
highest needs [52]. Screening for factors that negatively im-
pact QoL such as comorbidity, moderate to severe symptom
burden, psychological distress and fatigue should alert health
professionals to a potential need for support and allow earlier
intervention to improve QoL in those most affected [3, 53,
54].
As both the relaxation and exercise programmes demon-
strated significant improvement in QoL post-intervention, an-
other approach may be to integrate elements of both into one
programme. Lee et al. [55] also compared two interventions in
cancer survivors, one focusing on physical training (qigong)
and one on mental (stress management), to a control group.
These authors also found both groups demonstrated signifi-
cant improvement in physical and psychological functions at
12 weeks compared with a control group, and also recom-
mend that cancer survivors receive both physical and mental
support as they can benefit from both. Multimodal interven-
tions including both physical and psychological aspects have
also been recommended by others [17, 19, 56]. Further study
on the development of a multidimensional home-based inter-
vention including aspects of both relaxation and exercise in a
larger sample of lymphoma survivors is recommended in the
future.
Lee et al. [55] report that although educational resources
including DVDs and CDs were provided to encourage home
practice, lack of persistence can result from lack of supervi-
sion and peer encouragement, and they recommend continu-
ous and periodic involvement by professional coaches at a
minimum of once a week. A qualitative study to explore
gynaecological cancer survivors’ experience of a home-
based exercise intervention also found that weekly telephone
contact was favourable as it seemed to create an accountability
to exercise, linked with a rapport with the contacting therapist
[19]. In contrast, it has been stated that self-management in
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cancer survivorship should encompass understanding how
and when to seek support, making lifestyle changes to pro-
mote health and wellbeing, and the onus should be on indi-
viduals to initiate contact with healthcare professionals [4].
This latter approach was adopted for the REIL study, using
supported self-management during the transition phase. Here,
while both the relaxation and exercise interventions were self-
managed, participants were educated and advised to contact
the researcher (healthcare professional with expertise in can-
cer rehabilitation) any time additional support or advice was
required. In spite of evidence for the greater effectiveness of
supervised programmes, cancer survivors report a preference
for home-based and unsupervised exercise interventions for a
variety of reasons for instance to avoid travel, time commit-
ments, issues around cost, intimidation, and to avoid going
back to hospital [20, 21, 57]. Interventions tailored to individ-
ual need and preference are essential for maximising recruit-
ment and adherence and enhancing outcomes [21]. Home-
based interventions can also include motivational support
and guidance using distance-based approaches.
In the current climate of social distancing, distance-based
interventions may represent a more practical and accepted
method of support and rehabilitation for lymphoma survi-
vors. While several studies on self-management and
distance-based initiatives for cancer survivors including
telephone counselling [58], mobile applications [59] and in-
ternet [60] have demonstrated significant positive effects in-
cluding reduced physical side effects from treatment, re-
duced anxiety and depression, improved health behaviour
and increased QoL, these interventions have faced barriers
to implementation. Such barriers include not allocating re-
sources to ‘new’ initiatives, unfamiliarity with the internet,
reduced access to a smartphone and patient or healthcare
professional attitudes (e.g. preferring face-to-face consulta-
tion or reservations about new technology) [22]. However
distance-based strategies are now being promoted in most
populations, in particular those at risk of serious complica-
tions from coronavirus, such as cancer survivors. Key orga-
nisations in the UK including the NHS England [61] and the
Chartered Society of Physiotherapy (CSP) [62] now recom-
mend distance-based assessment and rehabilitation as the
primary strategy for cancer survivors where possible.
Based on a high trial adherence, the absence of adverse
events and positive satisfaction with the programmes [11],
the home-based interventions in this study are considered
feasible for lymphoma survivors in the transition phase.
These interventions require comparatively low resources
and personnel, incorporate the recommended elements of
self-management, use of patient-reported outcomemeasures
and tailored supportwhen required, and have demonstrated a
significant improvement in QoL; hence, such interventions
would continue to be effective and practical even on the re-
sumption of standard healthcare.
Strengths of the REIL study include testing of two theory-
based interventions, use of patient-reported outcome measures
and low dropout rates (17%). To our knowledge, this is the first
RCT directly comparing the efficacy of two interventions on
QoL; previous studies have used a comparison group as an active
control group [63]. While it was not an aim of this study to
directly evaluate the feasibility of the interventions, participants
who completed their interventions in both groups reported at the
end of the study questionnaire that they were able to fit this into
their daily life [11]. Limitations include the small sample size.
Difficulties were encountered with recruitment of eligible partic-
ipants including relapse or disease progression, impact of lym-
phoma and its treatment, scheduling difficulties and technical
problems. Similar problems have been reported in other studies
in cancer survivors [64]. While this study did not include mea-
sures to assess and encourage participant adherence such as daily
or weekly telephone calls or wearable activity trackers, the inter-
vention programmes were designed to be carried out in ‘real-
world’ settings and hence may be a more realistic representation
of what lymphoma survivors are able to undertake. Also, no
measures were taken to limit the practice of any other interven-
tions in each group. Hence, participants in the relaxation group
could have also taken up exercise on their own without being
advised to, and vice-versa; this potential contamination could
have biased results. However, once again, the addition of an
intervention as a supplement to normal life without limiting other
activities is a more realistic representation of real-world condi-
tions. The potential ceiling effect of the EORTCQLQ-C30 ques-
tionnaire as discussed and the inability to stratify the sample due
to small sample size for instance by physical activity are other
study limitations. Another limitation is the predominance of fe-
male patients in the study sample. This gender imbalance has
been reported in previous studies on interventions in cancer
survivors— the authors have reported a clear majority of female
participants from 73 to 87% [56]. This is in keeping with evi-
dence that participation in population-based research is generally
higher among women than among men [65]. Further research is
needed to give insight into this gender difference, and there is a
need for the development and testing of interventions with great-
er appeal to male cancer survivors [18, 65]. The principal inves-
tigator conducting both interventions also collected the data,
which may have led to bias. Self-selection of participants may
have resulted in a sample of lymphoma survivors who were
motivated to undertake a self-management intervention, but this
limitation is inherent in such studies.
Conclusions
Lymphoma survivors may experience decreased QoL follow-
ing chemotherapy and would benefit from assessment and re-
ferral for ongoing support and intervention as required. Based
on this study’s findings, a home-based exercise programme
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results in a greater improvement in QoL than a relaxation pro-
gramme. However, a relaxation programme would also have a
similar effect, albeit to a lesser extent. Referral to either pro-
gramme based on individual need and/or preference would aid
in improvement QoL post-chemotherapy. Both interventions
are an effective, feasible, less costly and more practical alterna-
tive to supervised group interventions in lymphoma survivors,
particularly in the current climate of the COVID-19 pandemic
and shielding of potentially vulnerable individuals.
Implications for Cancer survivors
Self-management programmes with support as required are
recommended for lymphoma survivors who demonstrate de-
creased QoL post-chemotherapy. A home-based exercise pro-
gramme appears more effective than a relaxation programme
in improving QoL and may be the favoured approach.
However, for patients who are unable to exercise or choose
not to, a home-based relaxation programme would also sig-
nificantly improve QoL. Multidimensional programmes com-
bining aspects of both may also be a way forward.
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